Abstract
In the version of this article originally published, data were incorrectly ascribed to monoclonal antibody CIS34 because of a labeling error. The data were generated with monoclonal antibody CIS04. The corrections are presented below.
Abstract
Published text: "Four of the five monoclonal antibodies (CIS23, CIS34, CIS42 and CIS43) showed dose-dependent binding to rPfCSP and PfSPZ in an ELISA and had maximal effective concentrations (EC 50 s) ranging 0.003-0.134 μ g/ml and 0.017-0.08 μ g/ml, respectively ( Fig. 1c ). " Correct text: "Four of the five monoclonal antibodies (CIS23, CIS04, CIS42 and CIS43) showed dose-dependent binding to rPfCSP and PfSPZ in an ELISA and had maximal effective concentrations (EC 50 s) ranging 0.003-0.134 μ g/ml and 0.017-0.08 μ g/ml, respectively ( Fig. 1c ). "
Abstract
Published text: "Four of the PfCSP-specific monoclonal antibodies (CIS23, CIS34, CIS42 and CIS43) that were isolated from memory B cells, and three of the PfCSP-specific monoclonal antibodies (mAb04, mAb09 and mAb10) isolated from plasmablasts showed dosedependent inhibition of sporozoite invasion of hepatocytes ( Supplementary Fig. 1b ). " Correct text: "Four of the PfCSP-specific monoclonal antibodies (CIS23, CIS04, CIS42 and CIS43) that were isolated from memory B cells, and three of the PfCSP-specific monoclonal antibodies (mAb04, mAb09 and mAb10) isolated from plasmablasts showed dosedependent inhibition of sporozoite invasion of hepatocytes ( Supplementary Fig. 1b ). "
Abstract
Published text: "Passive transfer of the monoclonal antibody CIS43 in mice following intravenous infection led to the highest reduction (~2-4 logs) of the liver-stage parasite burden in a dose-dependent manner (P < 0.008; Fig. 2a,b) as compared to the liver-stage parasite burden in untreated mice or those receiving transfection filtrate (mock); the second-highest reduction was observed following transfer of CIS34, which led to a ~2-log reduction (P < 0.008; Fig. 2a ). "
Fig. 1c,d:
"CIS04" should be present instead of "CIS34" in the key in Fig. 1c and in the image labels in Fig. 1d . Published text: "Differences between CIS43-, CIS34-and mAb10-treated mice and untreated mice were significant (P = 0.0001) (n = 7 mice per group per experiment). "
Fig. 1c,d:
Correct text: "Differences between CIS43-, CIS04-and mAb10-treated mice and untreated mice were significant (P = 0.0001) (n = 7 mice per group per experiment). " Supplementary Fig. 3a legend:
Fig. 1c,d:
Published text: "a, CIS23, CIS34, CIS42, mAb10. " Correct text: "a, CIS23, CIS04, CIS42, mAb10. " Supplementary Fig. 1b,c ,d,f: "CIS34" was replaced with "CIS04" in the x axes of Supplementary Fig. 1b ,c. The "CIS34" title was replaced with "CIS04" in Supplementary  Fig. 1d ,f. Supplementary Fig. 2a ,b,c:
Fig. 1c,d:
The "CIS34" title was replaced with "CIS04" in Supplementary Fig. 2a ,b,c. Supplementary Fig. 3a :
Fig. 1c,d:
The "CIS34" title was replaced with "CIS04" in Supplementary Fig. 3a. 

{'paper_id': '54631869', 'title': 'Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite', 's2_url': 'https://api.semanticscholar.org/CorpusID:54631869', 'source': 'S2ORC'}